Novel transcript, sense intronic to BCOR (null)

"Novel transcript, sense intronic to BCOR" (ENSG00000303056) is a long noncoding RNA gene identified as lying within an intronic region of the BCOR gene, transcribed in the sense direction. There is no evidence in current literature or databases that this locus encodes a protein or serves as a recognized therapeutic target, nor is its biological function or disease relevance defined. At present, this entity is annotated but otherwise uncharacterized and is not considered a canonical drug target[5]. The BCOR gene (BCL-6 corepressor) itself is a well-studied protein-coding locus involved in transcriptional repression, cancer biology, and developmental disorders, but ENSG00000303056 refers specifically to a different entity: a novel lncRNA overlapping BCOR[1][2][4][5][6]. The lncRNA designated by ENSG00000303056 is designated "novel" because there is no evidence yet supporting a specific function, biological process, or disease role for this transcript [5]. This locus does not map to any known druggable protein class or established biomarker panel. In summary, "novel transcript, sense intronic to BCOR" (ENSG00000303056) is not a canonical or characterized drug target or biomarker; it is a catalogued lncRNA with no defined function, targetability, or clinical relevance at present[5].

null